The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
- PMID: 32174888
- PMCID: PMC7057241
- DOI: 10.3389/fendo.2020.00078
The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
Abstract
Type 1 Diabetes (T1D) is regarded as an autoimmune disease characterized by insulin deficiency resulting from destruction of pancreatic β-cells. The incidence rates of T1D have increased worldwide. Over the past decades, progress has been made in understanding the complexity of the immune response and its role in T1D pathogenesis, however, the trigger of T1D autoimmunity remains unclear. The increasing incidence rates, immigrant studies, and twin studies suggest that environmental factors play an important role and the trigger cannot simply be explained by genetic predisposition. Several research initiatives have identified environmental factors that potentially contribute to the onset of T1D autoimmunity and the progression of disease in children/young adults. More recently, the interplay between gut microbiota and the immune system has been implicated as an important factor in T1D pathogenesis. Although results often vary between studies, broad compositional and diversity patterns have emerged from both longitudinal and cross-sectional human studies. T1D patients have a less diverse gut microbiota, an increased prevalence of Bacteriodetes taxa and an aberrant metabolomic profile compared to healthy controls. In this comprehensive review, we present the data obtained from both animal and human studies focusing on the large longitudinal human studies. These studies are particularly valuable in elucidating the environmental factors that lead to aberrant gut microbiota composition and potentially contribute to T1D. We also discuss how environmental factors, such as birth mode, diet, and antibiotic use modulate gut microbiota and how this potentially contributes to T1D. In the final section, we focus on existing recent literature on microbiota-produced metabolites, proteins, and gut virome function as potential protectants or triggers of T1D onset. Overall, current results indicate that higher levels of diversity along with the presence of beneficial microbes and the resulting microbial-produced metabolites can act as protectors against T1D onset. However, the specifics of the interplay between host and microbes are yet to be discovered.
Keywords: autoimmunity; environmental factors; longitudinal studies children; microbiome; type 1 diabetes.
Copyright © 2020 Dedrick, Sundaresh, Huang, Brady, Yoo, Cronin, Rudnicki, Flood, Momeni, Ludvigsson and Altindis.
Figures
Similar articles
-
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.Front Endocrinol (Lausanne). 2020 Mar 24;11:125. doi: 10.3389/fendo.2020.00125. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32265832 Free PMC article. Review.
-
Immune recognition and response to the intestinal microbiome in type 1 diabetes.J Autoimmun. 2016 Jul;71:10-8. doi: 10.1016/j.jaut.2016.02.004. Epub 2016 Feb 20. J Autoimmun. 2016. PMID: 26908163 Review.
-
Microbiota derived factors as drivers of type 1 diabetes.Prog Mol Biol Transl Sci. 2020;171:215-235. doi: 10.1016/bs.pmbts.2020.04.008. Epub 2020 Apr 29. Prog Mol Biol Transl Sci. 2020. PMID: 32475523
-
Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes.Int J Mol Sci. 2020 Dec 24;22(1):125. doi: 10.3390/ijms22010125. Int J Mol Sci. 2020. PMID: 33374418 Free PMC article. Review.
-
Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.Nutrients. 2015 Nov 6;7(11):9171-84. doi: 10.3390/nu7115461. Nutrients. 2015. PMID: 26561831 Free PMC article. Review.
Cited by
-
Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.BMJ Open. 2024 Feb 10;14(2):e076882. doi: 10.1136/bmjopen-2023-076882. BMJ Open. 2024. PMID: 38341215 Free PMC article.
-
Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice.NPJ Biofilms Microbiomes. 2024 Jan 6;10(1):1. doi: 10.1038/s41522-023-00475-4. NPJ Biofilms Microbiomes. 2024. PMID: 38182615 Free PMC article.
-
Burden of type 1 and type 2 diabetes and high fasting plasma glucose in Europe, 1990-2019: a comprehensive analysis from the global burden of disease study 2019.Front Endocrinol (Lausanne). 2023 Dec 13;14:1307432. doi: 10.3389/fendo.2023.1307432. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38152139 Free PMC article.
-
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091. Antioxidants (Basel). 2023. PMID: 38136211 Free PMC article. Review.
-
Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes.J Transl Int Med. 2023 Dec 20;11(4):363-371. doi: 10.2478/jtim-2023-0116. eCollection 2023 Dec. J Transl Int Med. 2023. PMID: 38130636 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
